NCT05077033View on ClinicalTrials.gov

Intratumoral phIL12 GET

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

November 30, 2023

Conditions
Basal Cell Carcinoma
Interventions
DRUG

phIL12 GET

intratumoral phIL12 gene electrotransfer

Trial Locations (2)

1000

Institute of Oncology Ljubljana, Ljubljana

University Medical Centre Ljubljana, Department of Otorhinolaryngology and Cervicofacial Surgery, Ljubljana

All Listed Sponsors
lead

Institute of Oncology Ljubljana

OTHER

NCT05077033 - Intratumoral phIL12 GET | Biotech Hunter | Biotech Hunter